Synodor Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-06-2024
- Paid Up Capital ₹ 0.30 M
as on 30-06-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 278570.00%
(FY 2022)
- Profit -13661.50%
(FY 2022)
- Ebitda -13661.50%
(FY 2022)
- Net Worth -4.55%
(FY 2022)
- Total Assets 4.70%
(FY 2022)
About Synodor Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Pathan and Parvez Pathan serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC354140
- Company No.
354140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Beed, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Synodor Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pathan  | Director | 27-Jan-2021 | Current |
| Parvez Pathan | Director | 27-Jan-2021 | Current |
Financial Performance and Corporate Structure Insights of Synodor Pharmaceuticals.
Synodor Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 278570% increase. The company also saw a substantial fall in profitability, with a 13661.5% decrease in profit. The company's net worth dipped by a decrease of 4.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synodor Pharmaceuticals?
Unlock access to Synodor Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synodor Pharmaceuticals?
Synodor Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synodor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synodor Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
